Cardiovascular comorbidity and its impact on patients with COVID-19

Wei-jie Guan, Wen-hua Liang, Jian-xing He, Nan-shan Zhong

Source: Eur Respir J, 55 (6) 2001227; 10.1183/13993003.01227-2020
Journal Issue: June
Disease area: -

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wei-jie Guan, Wen-hua Liang, Jian-xing He, Nan-shan Zhong. Cardiovascular comorbidity and its impact on patients with COVID-19. Eur Respir J, 55 (6) 2001227; 10.1183/13993003.01227-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015

Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003

Cardiovascular patients
Source: Eur Respir Monogr 2021; 90: 208-228
Year: 2021

Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 453s
Year: 2007

GRACE scores in COPD patients with acute coronary syndromes: Performance and impact on secondary prevention
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Fatigue in COPD and the impact of heart disease comorbidity: A population-based study
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011

Cardiovascular complications and comorbidities in CAP
Source: Eur Respir Monogr 2014; 63: 256-254
Year: 2014

Study of microalbuminuria in COPD patients and its association with cardiac comorbidities
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021

Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007

Global cardiovascular disease risk in U.S. adults by severity and presence of COPD
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015

Clinical characteristics and related risk factors of depression in patients with early COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients
Source: International Congress 2014 – Comorbidities
Year: 2014

Body composition in COPD patients with self-reported cardiovascular comorbidity
Source: Eur Respir J 2007; 30: Suppl. 51, 452s
Year: 2007

Psychiatric comorbidity in COPD and its determinants
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012

Prevalence and clinical correlates of patient-reported autonomic symptoms among subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014